Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Lung Neoplasms and FAT3[original query] |
---|
The correlation between crizotinib efficacy and molecular heterogeneity by next-generation sequencing in non-small cell lung cancer. Journal of thoracic disease 2018 May 10 (5): 2948-2959. Lv Tangfeng, Zou Qian, Song Zhengbo, Liu Hongbing, Wang Qiming, Song Yo |
Association of clinico-genomic characteristics with tumor mutational burden in small cell lung cancer patients. Future oncology (London, England) 2020 11 17 (4): 423-433. Kachroo Sumesh, Shao Changxia, Desai Kaushal, He Jinghua, Jin Fan, Sen Shuva |
Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation. Oncoimmunology 2021 2 10 (1): 1865670. Nie Wei, Gan Lu, Wang Xin, Gu Kai, Qian Fang-Fei, Hu Min-Juan, Zhang Ding, Chen Shi-Qing, Lu Jun, Cao Shu-Hui, Li Jing-Wen, Wang Yue, Zhang Bo, Wang Shu-Yuan, Li Chang-Hui, Yang Ping, Xu Mi-Die, Zhang Xue-Yan, Zhong Hua, Han Bao-H |
Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy. Frontiers in immunology 2021 12 800951. Zhu Mingyu, Zhang Lu, Cui Haiyan, Zhao Qiang, Wang Hao, Zhai Baochao, Jiang Richeng, Jiang Zhanshe |
Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas. Human pathology 2023 9 . Haiyue Wang, Linghua Yan, Yanli Zhu, Wei Sun, Xin Yang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Lixin Zhou, Dongmei L |
TP53 Exon 5 Mutation Indicates Poor Progression-Free Survival for Patients with Stage IV NSCLC. Frontiers in bioscience (Landmark edition) 2023 8 28 (7): 147. Huijing Feng, Huiru Xu, Xiuhuan Shi, Guobin Ding, Cihui Yan, Linhan Li, Zuoyi Jian, Xuejing Yang, Hongxia Guo, Feng Li, Junping Zhang, Xiubao R |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: